CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shanghai Shyndec Pharmaceutical Co Ltd Company Snapshot
Shanghai Shyndec Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Shyndec Pharmaceutical Co Ltd with three other companies in this sector in China: Harbin Gloria Pharmaceuticals Co., Ltd (2015 sales of 2.70 billion Chinese Renmimbi [US$394.80 million] of which 85% was Pharmaceutical Manufacturing), Jiangsu Kanion Pharmaceutical Co., Ltd. (2.82 billion Chinese Renmimbi [US$412.40 million] of which 100% was Exportation Trade), and Jiangzhong Pharmaceutical Company Limited (2.60 billion Chinese Renmimbi [US$379.59 million] of which 68% was Medical Industry).

Sales Analysis. During the year ended December of 2015, sales at Shanghai Shyndec Pharmaceutical Co Ltd were 2.68 billion Chinese Renmimbi (US$392.17 million). This is a decrease of 2.4% versus 2014, when the company's sales were 2.75 billion Chinese Renmimbi. Contributing to the drop in overall sales was the 99.1% decline in Trade, from 211.29 million Chinese Renmimbi to 1.95 million Chinese Renmimbi. There were also decreases in sales in Information Services (down 10.2% to 25.14 million Chinese Renmimbi) . However, these declines were partially offset by the increase in sales of Drug Products (up 2.8% to 1.99 billion Chinese Renmimbi) and Raw Material (up 13.7% to 652.68 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shanghai Shyndec Pharmaceutical Co Ltd
  Stock Performance Chart for Shanghai Shyndec Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (1/20/2017): 30.98
(Figures in Chinese Renmimbi)
1 Week -0.8%   13 Weeks -0.4%  
4 Weeks 2.7%   52 Weeks n/a  
 
Shanghai Shyndec Pharmaceutical Co Ltd Key Data:
  Ticker: 600420 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 2,682,067,174
(Year Ending Jan 2016).
Employees: 5,695
  Currency: Chinese Renmimbi Market Cap: 8,913,980,794
  Fiscal Yr Ends: December Shares Outstanding: 287,733,402
  Share Type: A SHARES Closely Held Shares: 153,466,989
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.